Clinical utility of proPSA and “benign” PSA when percent free PSA is less than 15%
| Autor: | Khan, Masood A. a, Sokoll, Lori J. a, b, 1, Chan, Daniel W. a, b, 1, Mangold, Leslie A. a, Mohr, Phaedre b, Mikolajczyk, Stephen D. c, Linton, Harry J. c, Evans, Cindy L. c, Rittenhouse, Harry G. c, Partin, Alan W. a, b, *, 1 |
|---|---|
| Zdroj: | In Urology 2004 64(6):1160-1164 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect